PRCT vs. PSEC

Last updated Apr 1, 2026

Compare and contrast key facts about PROCEPT BioRobotics Corporation (PRCT) and Prospect Capital Corporation (PSEC).

Performance

PRCT vs. PSEC - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in PROCEPT BioRobotics Corporation (PRCT) and Prospect Capital Corporation (PSEC). The values are adjusted to include any dividend payments, if applicable.

PRCT vs. PSEC - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
PRCT PROCEPT BioRobotics Corporation	-20.50%	-60.93%	92.13%	0.89%	66.09%	-40.37%
PSEC Prospect Capital Corporation	5.88%	-28.86%	-18.16%	-4.13%	-8.61%	9.52%

Fundamentals

EPS PRCT : -$2.58 PSEC : -$0.86
PS Ratio PRCT : 3.01 PSEC : 61.69
Total Revenue (TTM) PRCT : $308.05M PSEC : $12.64M
Gross Profit (TTM) PRCT : $196.23M PSEC : -$212.47M
EBITDA (TTM) PRCT : -$89.40M PSEC : -$257.87M

Returns By Period

In the year-to-date period, PRCT achieves a -20.50% return, which is significantly lower than PSEC's 5.88% return.

PRCT

• 1D: -2.11%
• 1M: 10.22%
• YTD: -20.50%
• 6M: -29.92%
• 1Y: -57.07%
• 3Y*: -4.15%
• 5Y*: —
• 10Y*: —

PSEC

• 1D: 3.98%
• 1M: -2.32%
• YTD: 5.88%
• 6M: 4.98%
• 1Y: -23.27%
• 3Y*: -16.65%
• 5Y*: -9.07%
• 10Y*: 1.82%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

PRCT vs. PSEC — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

PRCT

PRCT Risk / Return Rank: 7
PRCT Sharpe Ratio Rank: 5
PRCT Sortino Ratio Rank: 5
PRCT Omega Ratio Rank: 7
PRCT Calmar Ratio Rank: 8
PRCT Martin Ratio Rank: 12

PSEC

PSEC Risk / Return Rank: 16
PSEC Sharpe Ratio Rank: 12
PSEC Sortino Ratio Rank: 13
PSEC Omega Ratio Rank: 15
PSEC Calmar Ratio Rank: 17
PSEC Martin Ratio Rank: 23

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

PRCT vs. PSEC - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for PROCEPT BioRobotics Corporation (PRCT) and Prospect Capital Corporation (PSEC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	PRCT	PSEC	Difference
Sharpe ratio Return per unit of total volatility	-0.97	-0.69	-0.28
Sortino ratio Return per unit of downside risk	-1.61	-0.90	-0.72
Omega ratio Gain probability vs. loss probability	0.82	0.90	-0.07
Calmar ratio Return relative to maximum drawdown	-0.90	-0.72	-0.18
Martin ratio Return relative to average drawdown	-1.42	-1.04	-0.38
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

PRCT vs. PSEC - Sharpe Ratio Comparison

The current PRCT Sharpe Ratio is -0.97, which is lower than the PSEC Sharpe Ratio of -0.69. The chart below compares the historical Sharpe Ratios of PRCT and PSEC, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	PRCT	PSEC	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.97	-0.69	-0.28
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	-0.33	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	0.07	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.17	0.09	-0.26

Correlation

The correlation between PRCT and PSEC is 0.27, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

PRCT vs. PSEC - Dividend Comparison

PRCT has not paid dividends to shareholders, while PSEC's dividend yield for the trailing twelve months is around 20.69%.

	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
PRCT PROCEPT BioRobotics Corporation	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
PSEC Prospect Capital Corporation	20.69%	20.85%	16.01%	12.02%	10.30%	8.56%	13.31%	11.18%	11.41%	13.45%	11.98%	14.72%

Drawdowns

PRCT vs. PSEC - Drawdown Comparison

The maximum PRCT drawdown since its inception was -77.18%, which is greater than PSEC's maximum drawdown of -61.51%. Use the drawdown chart below to compare losses from any high point for PRCT and PSEC.

Drawdown Indicators

	PRCT	PSEC	Difference
Max Drawdown Largest peak-to-trough decline	-77.18%	-61.51%	-15.67%
Max Drawdown (1Y) Largest decline over 1 year	-65.12%	-32.01%	-33.11%
Max Drawdown (5Y) Largest decline over 5 years	—	-55.18%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-55.18%	—
Current Drawdown Current decline from peak	-74.85%	-48.91%	-25.94%
Average Drawdown Average peak-to-trough decline	-30.01%	-15.32%	-14.69%
Ulcer Index Depth and duration of drawdowns from previous peaks	40.98%	22.63%	+18.35%

Volatility

PRCT vs. PSEC - Volatility Comparison

PROCEPT BioRobotics Corporation (PRCT) has a higher volatility of 21.09% compared to Prospect Capital Corporation (PSEC) at 9.13%. This indicates that PRCT's price experiences larger fluctuations and is considered to be riskier than PSEC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	PRCT	PSEC	Difference
Volatility (1M) Calculated over the trailing 1-month period	21.09%	9.13%	+11.96%
Volatility (6M) Calculated over the trailing 6-month period	44.70%	24.68%	+20.02%
Volatility (1Y) Calculated over the trailing 1-year period	58.84%	33.68%	+25.16%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	64.84%	27.28%	+37.56%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	64.84%	26.86%	+37.98%

Financials

PRCT vs. PSEC - Profitability Comparison

The chart below illustrates the profitability comparison between PROCEPT BioRobotics Corporation and Prospect Capital Corporation over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

PRCT - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, PROCEPT BioRobotics Corporation reported a gross profit of 46.31M and revenue of 76.38M. Therefore, the gross margin over that period was 60.6%.

PSEC - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Prospect Capital Corporation reported a gross profit of 0.00 and revenue of 133.90M. Therefore, the gross margin over that period was 0.0%.

PRCT - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, PROCEPT BioRobotics Corporation reported an operating income of -31.04M and revenue of 76.38M, resulting in an operating margin of -40.6%.

PSEC - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Prospect Capital Corporation reported an operating income of 0.00 and revenue of 133.90M, resulting in an operating margin of 0.0%.

PRCT - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, PROCEPT BioRobotics Corporation reported a net income of -29.85M and revenue of 76.38M, resulting in a net margin of -39.1%.

PSEC - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Prospect Capital Corporation reported a net income of 0.00 and revenue of 133.90M, resulting in a net margin of 0.0%.